GlycoNex (ROCO:4168) Change In Other Working Capital : NT$-5.88 Mil (TTM As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is GlycoNex Change In Other Working Capital?

GlycoNex's Change In Other Working Capital for the quarter that ended in Mar. 2025 was NT$23.69 Mil. It means GlycoNex's Other Working Capital increased by NT$23.69 Mil from Dec. 2024 to Mar. 2025 .

GlycoNex's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was NT$5.73 Mil. It means GlycoNex's Other Working Capital increased by NT$5.73 Mil from Dec. 2023 to Dec. 2024 .

GlycoNex Change In Other Working Capital Historical Data

The historical data trend for GlycoNex's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlycoNex Change In Other Working Capital Chart

GlycoNex Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

2.00

1.23

13.35

2.19

5.73

GlycoNex Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial															35.29	-47.95	17.38	1.00	23.69

GlycoNex Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-5.88 Mil.

GlycoNex Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of GlycoNex's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

GlycoNex Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoNex Inc (ROCO:4168) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221

Website

http://www.glyconex.com.tw

GlycoNex Inc is a Taiwan based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies that targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability, and can serve as reagents with applications that include ELISA, Western blot, flow cytometry, and TLC immunostaining. The Company also provides antibody research services to its academic and industrial clients. The other services provided by the firm include functional evaluation and antibody engineering. The company has two segments which are antibody new drugs and exclusive investment. It earns the majority of its revenue from the antibody new drugs segment.

GlycoNex Headlines

No Headlines